Veteran actor and social figure Nafisa Ali has announced that her ongoing battle with stage four cancer has entered a new phase. According to recent updates shared by the artist, the illness has advanced to the surface of her liver, prompting her medical team to adjust her treatment plan to include targeted therapy.
The performer, who has been managing her health from her home in Goa, shared a photograph from a medical facility on social media to keep her followers informed. Accompanied by the image, she expressed a resilient mindset, describing the situation as continuing to fight the good fight as she undergoes the newly prescribed regimen.
The announcement drew an immediate outpouring of affection and encouragement from friends, colleagues, and fans across the entertainment and fashion industries. Prominent figures, including fashion designer Farah Khan Ali, were among the many well-wishers who publicly sent messages of strength and solidarity to the veteran star.
The actor was first diagnosed with peritoneal and ovarian cancer back in 2018. Throughout her long journey with the disease, she has maintained a transparent approach regarding her medical updates, frequently using her platform to raise awareness and share glimpses of her resilience with the public.
Targeted therapy represents a specialized form of cancer treatment designed to home in on specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. Unlike traditional chemotherapy, which can affect both healthy and cancerous cells, these medications block the spread of cancer cells while limiting damage to normal tissues.
As she embarks on this latest chapter of her medical journey, supporters continue to rally around the beloved artist. Her openness about the progression of the disease underscores a steadfast commitment to facing the condition head-on while continuing to inspire others with her enduring positivity.
Reporting based on coverage first published by The Times of India. Read the original report at The Times of India.
